There were 1,801 press releases posted in the last 24 hours and 442,347 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image